ic chromosomal abnormalities of medulloblastomas and PNETs are losses of chromosome 17p, usually through the formation of an i(17q). 8, 11, 14, 23 In addition to the loss of 17p, there are numerical and structural changes that involve several other chromosomes that are nonrandomly associated with medulloblastoma and PNET. An extra copy of chromosome 7, often seen in tumors with an i(17q), is the second most common cytogenetic abnormality. 7, 8, 11, 23 Additional findings in small subsets of tumors, detected either by cytogenetic analysis or by LOH allelotyping, included the detection of deletions on chromosomes 5q, 6, 9, 10, 11, 16q, and 22. 2, 11, 14, 25, 40, 53 Amplification in the form of double-minute chromosomes or homogeneously staining regions are seen in approximately 3 to 5% of medulloblastomas and PNETs, and are commonly found to contain amplification of either the MYCC or MYCN oncogene. 6, 8, 12, 13, 15, 26 Six CGH studies on PNETs have been conducted to date. 3, 34, 36, 41, 44, 48 Researchers in these studies have identified novel regions of amplification at 1p32-p34, 3p21.2-p22, 4q12-13, 5p15.3, and 11q22.3, as well as nonrandom gains and losses of chromosomes 1q, 3, 7, 8q, 10q, 11, 16q, and 17. Recently, Nicholson and associates 34 correlated the variables of site and histological characteristics in 37 PNETs with chromosomal copy number changes. These researchers found no abnormalities of chromosome 17 in cerebral PNETs. Tumors with an i(17q) or a gain of 17q showed no evidence of glial differentiation in the form of immunoreactivity for GFAP. Similarly, Russo, et al., 44 analyzed a series of 53 tumors by using CGH and found that the patterns of chromosomal change in supratentorial and infratentorial PNETs were different, suggesting that these two tumor types have distinct molecular changes.
Recent advances in molecular cytogenetic procedures have allowed for the detection of subtle chromosomal rearrangements that otherwise might have gone undetected by conventional G-banding analysis alone. 46 ,51 Spectral karyotyping is a multicolored FISH procedure that allows for the simultaneous detection of all chromosomes in the genome in one experiment. 46 Spectral karyotyping has become a powerful tool in detecting complex chromosomal rearrangements, including the chromosomal origins of marker chromosomes, and elucidating structural rearrangements that may provide more insight into the nature of the disease. 22, 24, 35, 39, 42, 43, 47, 50, 54, 55 Together with other methods such as G-banding, CGH, FISH, and traditional molecular assays, the amount of information that can be generated from one specimen has greatly increased. We suggest that these processes are complementary and that in combination they will identify abnormalities not detectable by conventional cytogenetic analysis alone.
In this retrospective study, we analyzed 24 pediatric cases, including 19 medulloblastomas and five PNETs, by using conventional G-banding, CGH, SKY, FISH, and semiquantitative PCR, either alone or in combination. The goal of this study was to screen our series of tumors to determine the chromosomal changes that occur both numerically and structurally, and to determine whether there are consistent rearrangements or translocations specific to medulloblastomas and PNETs. This study also tracks the evolution of molecular cytogenetic technology over the past decade and its impact on chromosomal studies.
Materials and Methods

Study Group
Tumor specimens were obtained from 24 patients with medulloblastomas or supratentorial PNETs who were treated at the Hospital for Sick Children during the period from 1991 to 1999. Because the majority of cases were studied retrospectively, in most instances stored cytogenetic preparations were not suitable for SKY and there were not adequate samples of DNA for CGH analysis of every tumor. Five cases were analyzed using SKY; in three cases the analysis focused on archived fixed suspensions and in two cases on fresh cultures. The average age of the patients from whom samples were obtained was 6.1 years with a range of 9 months to 12 years.
Tumor Specimens
All 24 tumor specimens were evaluated according to standard histopathological methods by using the revised World Health Organization classification system. 29 All tumors located in the cerebellum were considered medulloblastomas, whereas histologically similar tumors occurring in the cerebrum were designated PNETs. Standard histopathological and immunohistochemical methods were used. Glial, neuronal, and ependymal differentiation was judged according to tissue immunoreactivity for GFAP, synaptophysin, and neurofilament, as well as by using electron microscopy. The samples were obtained at the time of surgery and snap frozen or taken directly for tissue culturing. The DNA was extracted from fresh or frozen tissue by using standard phenol-chloroform extraction methods. 19 
Cytogenetic Analysis
Tumor specimens were processed for short-term culture in highglucose Dulbecco's modified Eagle's medium (4.5 g/L) supplemented with 15% fetal calf serum, 1% penicillin/streptomycin, and 1% L-glutamine. The cultures were harvested using 0.1 g/ml colcemid for 2 to 4 hours, hypotonically treated with 0.075 M KCl, and fixed in methanol/acetic acid (3:1). The slides were dropped and aged for 2 to 3 days, after which they were stained with Giemsa. Whenever possible 10 G-banded metaphases were analyzed using conventional G-banding methods 19 according to standard procedures, and immediately destained and dehydrated for subsequent FISH or SKY analysis.
Spectral Karyotyping
Spectral karyotyping was performed using either freshly prepared slides 39 or previously banded slides that were less than 2 months in age. The quality of the archival specimens was assessed according to their age, chromosome morphological characteristics, and other parameters described by Bayani, et al. 5 The assay was performed using SKYPaints according to the manufacturer's instructions. 46 Briefly, previously G-banded slides were destained, formalin fixed, and denatured in 70% formamide/2 ϫ SSC at 75˚C for 40 seconds. The SKYPaints were denatured, preannealed, and hybridized to the denatured slides for 24 hours at 37˚C. Posthybridization washes and detections were conducted according to the manufacturer's instructions. Spectral images were acquired and analyzed using a spectral bioimaging system attached to a microscope. Generation of a spectral image was achieved by obtaining approximately 100 frames of the same image that differed from each other only in optical path difference. The images were stored in a computer for further analysis by using appropriate software. For every chromosomal region, identity was determined by measuring the spectral emission at that point. Regions at which sites for rearrangement or translocation between different chromosomes occurred were visualized by a change in the display color at the point of transition. Pseudocolor classifications were made to aid in the delineation of specific structural aberrations in which the display color of different chromosomes would have appeared quite similar.
Comparative Genomic Hybridization
Metaphase spreads from normal human lymphocytes were pre-J. Bayani, et al. pared using standard protocols. 19 The slides were aged for 2 to 3 days before denaturation at 72˚C was performed using 70% formamide/2 ϫ SSC, followed by dehydration in a graded series of ethanol. The slides were treated with proteinase K at a concentration of 0.1 g/ml in 20 mM Tris (pH 7.5)/2 mM CaCl 2 before hybridization. Nick-translated, biotin-labeled tumor DNA and digoxigeninlabeled normal DNA were coprecipitated with excess unlabeled human Cot-1 DNA, denatured, and hybridized to the normal metaphase slide preparations. The CGH procedure was similar to published standard protocols. 27, 39 Ten to 12 images were captured using a microscope equipped with an automatic filter wheel and an 83,000 filter set with single-band-pass exciter filters for ultraviolet FITC (490 nm), DAPI (360 nm), and rhodamine (570 nm). The images were analyzed using an imaging system, a CGH karyotyper, and an interpreter. Using this software, the ratio of the FITC/rhodamine signal is expressed as the green/red ratio and a deviation from a 1:1 ratio indicates gain or loss of chromosome material. Thus, an increase in the green/red ratio indicates a gain of chromosomal material in the tumor and, conversely, a decrease in the green/red ratio indicates a loss of genomic material in the tumor (or an overrepresentation of genomic material in normal tissue). The lower and upper limits for gain and loss were established by performing control CGH experiments using IMR32, a well-characterized neuroblastoma cell line, and DNA derived from male and female normal tissue. Based on these findings, the cutoff values were set at 1.2 and 0.8, with a 95% confidence limit. Gene amplification was defined as gain ratios greater than 1.5.
Fluorescence In Situ Hybridization
Fluorescence in situ hybridization was performed on unstained slides under standard conditions. 19 Slides were ethanol dehydrated and denatured in 70% formamide/2 ϫ SSC at 72˚C for 2 minutes, after which they were subjected to a final ethanol-induced dehydration. The slides were then allowed to hybridize with locus-specific probes for 24 hours. Posthybridization washes and detections were performed at 45˚C and 37˚C, respectively, and the slides were mounted in a DAPI/antifade mounting medium. Commercially available locus-specific MYCN and MYCC probes were used for the FISH analysis. The slides were then imaged using an appropriate imaging system.
Semiquantitative PCR Analysis
Semiquantitative PCR analysis was conducted in a manner previously described to determine the relative copy numbers of MYCN. 16 
Sources of Supplies and Equipment
Sigma Chemical Co. (St. Louis, MO) supplied the fetal calf serum and Gibco BRL (Gaithersburg, MD) the penicillin/streptomycin, L-glutamine, and colcemid. For the SKY experiments, we used SKYPaints and SKYView software (version 1.2) manufactured by Applied Spectral Imaging, Inc. (Carlsbad, CA), and the SD200 spectral bioimaging system, which we purchased from Applied Spectral Imaging, Ltd. (Migdal Ha'Emek, Israel). The Axioplan 2 microscope was acquired from Carl Zeiss Canada, Ltd. (North York, ON, Canada). For the CGH experiments, we used a Labophot 2 microscope, which we obtained from Nikon Canada, Inc. (Mississauga, ON, Canada). The microscope was equipped with an automatic filter wheel and filter set obtained from Chroma (Brattleboro, VT). We also used the Quips SmartCapture Imaging System, Quips CGH/Karyotyper, and Quips Interpreter, which we purchased from Vysis (Downers Grove, IL). For the FISH experiments, we used DAPI/antifade mounting medium and MYCN and MYCC probes, which we acquired from Oncor (Intergen Co., Gaithersburg, MD), and the Vysis Quips SmartCapture Imaging System.
Results
Pathological Characteristics of the Patient Group
A summary of the histopathological and immunohistochemical characteristics of the tumors including a breakdown of glial, neuronal, and ependymal differentiation are summarized in Table 1 . The study group included 19 medulloblastomas, of which 11 were classic, six desmoplastic, and two large-cell medulloblastomas. In the remaining five cases, the tumors were located in the cerebrum and were thus designated supratentorial PNETs.
Cytogenetic Findings
In 21 tumors metaphase preparations could be produced (Table 2 ). In the remaining three cases, there was insufficient material for tissue-culture studies. Of the 21 cases in which metaphase spreads were produced, there were 15 with metaphase spreads of adequate quality for a full cytogenetic analysis. Partial analysis was possible in the remaining six cases, allowing identification of chromosome number as well as any other structural anomalies including double-minute chromosomes, ring chromosomes, and chromosome markers. Of the 15 tumors that were karyotyped, chromosomes 3, 6, 7, 10, 14, 17, 18, and 22 were most commonly found to be affected by gains or losses or involved in rearrangements or translocations. In determining the frequency of chromosomal change (as a percentage), the total number of gains, losses, and rearrangements for each chromosome was divided by the total number of gains, losses, and rearrangements observed in the 15 cases (78 in all). The results are graphed in Fig. 1 . Chromosomes 6, 7 and 14 scored the highest frequency of rearrangement at 9%, followed by chromosomes 3, 5, 10, 13, 18, and 22 at a frequency of 7.7%, and, finally, chromo-
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Molecular cytogenetic analysis of medulloblastomas and PNETs (5),+der(5),-10,del(11)(p) -* The G-banded derived karyotypes represent the clonal population contributing to the composite karyotype. In instances in which adequate banding was not possible, numerical counts were made with notations concerning obvious chromosome markers and double-minute chromosomes (dmins) or ring chromosomes. The SKY data refer to one composite karyotype, but in some instances sublines are represented. Other molecular assays performed in these cases are also listed. Abbreviations: F = FISH, SQP = semiquantitative PCR; -= not performed.
439
some 17 at a frequency of 6.4%. Figure 2 shows that the overall pattern of numerical change is pseudotriploid, with many structural changes present. Cytogenetic evidence of gene amplification was substantiated by molecular assays or FISH, confirming high copy number levels (see Discussion).
Comparative Genomic Hybridization
Comparative genomic hybridization was performed in 10 tumors and is summarized in Fig. 3 . Of the 10 tumors, nine were found to possess abnormal CGH profiles, whereas the remaining one had a normal profile. In most cases, CGH results confirmed those of initial G-banding and helped to identify the chromosomal origins of structural aberrations such as double-minute chromosomes, rings, and unbalanced translocations. Analysis of the CGH results revealed a gain of part or all of chromosomes 7 and/or 17 in 60% of the tumors. Gains of part or all of chromosomes 1 and/or 3 were detected in 20% of the tumors, and losses appeared to be restricted to chromosomes 4, 12, and 19 (each in 20% of tumors). High-level gains and amplifications were detected at 2p24 (MYCN), 8q23 (MYCC), and at 9p (Fig. 4) . The overall frequency of change for the 10 cases is summarized in Table 2 . The percentage of chromosomal change was found to be similar to that found using conventional G-banding methods. The most commonly altered chromosomes were 7 (11.3%) and 17 (13.2%), followed by 8 (7.5%) and 2, 3, 4, 9, 19, and 20 (each 5.7%). Chromosomes 6 and 10 did not exhibit any evidence of copy number alterations, whereas chromosome 17 was found to be aberrant by a significantly greater percentage when CGH was performed than when G-banding was used. In Case 20, a normal CGH profile was generated, in contrast to the findings of cytogenetic analysis, which had revealed chromosomal changes. Cytogenetic analysis in this case detected a reciprocal translocation between chromosomes 6 and 13. As would be expected when using CGH, a normal profile was obtained because this balanced rearrangement resulted in no net gain or loss of DNA.
Spectral Karyotyping Findings
Spectral karyotyping was performed in five cases. Three tumors (Cases 20, 22, and 23) were analyzed using archived fixed-cell suspensions and the remaining two tumors (Cases 21 and 24) were analyzed using fresh shortterm cultures when there was also adequate tissue for CGH analysis. The percentage frequency of chromosomal change based on the SKY analysis is graphed in Fig. 1 . The total number of rearrangements was 70 for all five cases. Chromosomes 3, 7, 14, and 22 were each rearranged at a frequency of 10%, which is comparable to the G-banding results. Similarly, chromosomes 6 and 10 were rearranged 8.6% of the time. Chromosomes 5, 13, 17, and 18 were each found to be rearranged 7.1% of the time. The SKY analysis of Case 20 detected no chromosomal aberrations other than the original G-banded karyotype and confirmed the balanced translocation between chromosomes 6 and 13. Case 21 had a chromosomal range of 99 to 105 chromosomes. Banding analysis of this case was incomplete due to the lack of long chromosomes for adequate karyotyping. However, SKY analysis (Fig. 5) identified the karyotype to be hypotetraploid. In the same case, CGH analysis identified a net gain of chromosomes 1, 17, 18, and 20 and a net loss of chromosome 3. The SKY karyotype of one representative metaphase demonstrated extra copies of chromosomes 1, 17, 18, and 20, as well as loss of chromosome 3 (Fig. 5 lower) . Cytogenetic analysis identified a Yp+ in Case 22 and SKY analysis determined the Yp+ to be a translocation between chromosome 15 and Y. Furthermore, analysis of five metaphases detected the following clonal changes: loss of chromosomes 5, 12, and 21, and gain of chromosomes 8 and 11. Thus, the increased sensitivity of SKY for detecting subtle changes permitted the G-banded analysis to be reinterpreted in this case. Case 23 was found to have a karyotype with three stem lines. Common aberrations that were present included translocations between chromosomes 1 and 7, creating a der(1)t(1;7)(p36;?), and chromosomes 15 and 21, yielding a der(15)t(15;21)(?;?). Double-minute chromosomes were identified using SKY to be material originating from chromosome 2. The FISH analysis performed using the MYCN probe confirmed MYCN amplification on the double-minute chromosomes (data not shown). Case 24 ( Fig.  6 ) was analyzed using G-banding, CGH, and SKY. The clonal changes were confirmed using SKY, with a refined identification of the +der(?)(6? or 10?;14), detected by G-banding, as being a rearrangement between chromo-J. Bayani, et al. somes 10 and 14: der(10)t(10;14)(q23?;q31?). The SKY analysis also permitted the identification of the marker chromosome as being material originating from chromosome 5. The CGH analysis in this case detected a gain of material from 5p and 7q, confirming the SKY and G-banding identification. Taken together, these data provide a more comprehensive analysis of this tumor because we now have identified the markers to be material specifically from 5p; the unbalanced translocation between chromosomes 3 and 7, as well as the i(7q), yielding extra material from 7q. Other random gains and losses of chromosomes were also detected throughout the karyotype.
Fluorescence In Situ Hybridization and Semiquantitative PCR
In cases in which the appropriate material was available, FISH or semiquantitative PCR was performed to confirm the results generated by the cytogenetic, CGH, or SKY studies. The results of these studies are listed in Table 2 . In all cases, FISH and semiquantitative PCR were able to confirm the existence of amplified sequences of MYCN or MYCC (data not shown).
Discussion
Primary brain tumors represent the most common solid tumor occurring in childhood. A number of factors, such as tumor heterogeneity, tissue-culturing limitations, and biopsy size and quality, hinder the researcher's ability to provide an exhaustive cytogenetic and molecular analysis. 7, 13, 23 Recent reviews of studies of the cytogenetic and molecular characteristics of childhood brain tumors completed during the past decade have drawn attention to specific chromosomal changes in medulloblastomas and PNETs as potential recurrent markers of this disease. 7, 8 More recently, CGH analysis has led to the determination of nonrandom gains and losses of specific chromosomes or chromosomal regions. 34, 44 The ability to apply SKY to medulloblastoma and PNET chromosomal preparations has provided an opportunity to complement previous cytogenetic methods with a more comprehensive and detailed survey of structural rearrangements in this tumor group.
By far the most consistent cytogenetic observation is the loss of 17p and/or the formation of an i(17q) observed in approximately one third of medulloblastomas and PNETs. 10, 11, 14, 23 Although the p53 gene is located on chromosome 17, it is infrequently mutated in medulloblastomas, suggesting that an as yet unknown gene may be the target of 17p loss in these tumors.
1,4,9,37 Interphase FISH 10 and microsatellite analysis 2, 25 have shown that the breakpoint cluster region is at 17p11.2, between the centromere and the proximal 17. The proximity of the breakpoint region to the centromere suggests that the tendency for i(17q) formation may be due to the number of repeated sequences present in the pericentromeric region, 10, 45, 56 and that these regions per se do not harbor a tumor suppressor gene. Rather, the combination of 17q gain and 17p loss may provide a selective growth advantage to medulloblastomas, leading to tumor progression. This region of chromosome 17 is frequently involved in chromosomal breaks or deletions, leading to a number of different nonneoplastic disorders including Smith-Magenis syndrome, Charcot-Marie-Tooth disease Type 1A, and hereditary neuropathy with liability to pressure palsies. 17, 49 Taken together these observations suggest that this region of chromosome 17 may be intrinsically more unstable and prone to genomic rearrangement.
The second most consistent observation is the gain of chromosome 7, which is often seen in combination with a gain of 17q. 7, 11, 23 In a recent study, El-Naggar and colleagues 21 analyzed a number of hypodiploid tumors, including breast, kidney, lung, uterus, ovarian, and oral carcinomas, in which both flow cytometry and FISH were used to determine whether specific chromosomes were more likely to be lost or gained. The results of their study revealed that the gain of chromosome 7 and the loss of chromosome 17 were the most common aneusomies in hypodiploid tumors. This suggests a cooperative selective growth advantage may exist, thus explaining the amount of changes seen in both chromosomes. In medulloblastomas such a pattern may also be emerging because monosomy of 22, i(17q), monosomy of 8, and add8(p11.2), together with trisomy of 7 and gain of 1q, appear frequently in combination. 7, 8 To date, most surveys of medulloblastomas and PNETs have concentrated on either classic cytogenetic analysis alone or purely genomic analysis performed using CGH. Cytogenetic analysis and/or LOH allelotyping have been used to detect deletions of loci on chromosomes 5q, 6, 9, 10, 11, 16q, and 22. 2, 11, 14, 25, 40, 53 Previous studies performed by James and coworkers 25 focused on restriction fragment length polymorphism studies of chromosomes 10, 17, and 22 and indicated loss of sequence at various loci. In our study, we combined structural rearrangement observations derived from classic cytogenetics with genomic changes data determined using CGH and SKY. Together three assays provide more comprehensive information on genomic changes in this tumor type. The results in our patient group revealed no specific chromosomal differences between the 19 medulloblastomas and five PNETs. Other groups, however, have identified a trend of genomic gain and loss that is specific to medulloblastoma and PNET subgroups. 44 Because of the small size of our patient group, the results obtained in both medulloblastomas and PNETs have been combined. The data from all three assays revealed the highest frequency of chromosomal alteration (including gains, losses, translocations, and rearrangements) among chromosomes 3, 7, 10, 14, 17, and 22, followed by chromosomes 6, 13, and 18 (Fig. 7) . Although our findings of significant involvement of chromosomes 7, 17, 10, and 22 support the current literature, we have additionally found an increase in the chromosomal rearrangement of chromosomes 3, 6, 13, 14, and 18, particularly in translocations in near-diploid karyotypes.
Cytogenetic and SKY analysis of the 19 medulloblastomas revealed karyotypes that in general were nearly diploid, with a number of cases also showing aneuploidy, unbalanced translocations, and numerous structural rearrangements in the form of double-minute, ring, and marker chromosomes. These karyotypes also exhibited a higher degree of karyotype heterogeneity than previously reported. Six of the medulloblastomas were of the desmoplastic subtype, revealing karyotypes that were also diploid or diploid with tetraploid populations, as well as the presence of structural aberrations including marker chromosomes and double-minute chromosomes. The desmoplastic medulloblastomas exhibited karyotypes with more numerical variation than that found in classic medulloblastomas. The five PNET cases in this study revealed a range of aneusomy from diploid to triploid to tetraploid karyotypes. Two medulloblastomas were described as large cell medulloblastomas and were characterized by the presence of high-level gene amplification (MYCC or MYCN). Gene amplification in PNETs has been described 8, 12, 13, 15 and is believed to confer a worse prognosis. Amplification in the form of double-minute chromosomes was present in the PNET group of tumors in this study. It was also observed that gene amplification was limited to the desmoplastic, large-cell, and PNET cases, with one classic medulloblastoma case showing double-minute chromosomes in the karyotype. Significantly, gene amplification in the form of double-minute chromosomes was found in only a subset of metaphases, suggesting heterogeneity of gene amplification within this tumor. Known J. Bayani, et al. to confer a worse prognosis in neuroblastomas, gene amplification, including heterogeneous gene amplification within tumors, previously was well documented 28, 30, 52 and likely represents a later event in tumor progression.
A survey of the immunohistochemical results indicates that, among the 19 medulloblastomas, those cases that exhibited evidence of gross cytogenetic abnormalities such as marker, double-minute, or ring chromosomes were immunopositive for one or both of the markers for neuronal or glial differentiation. Similarly among the four of five PNETs in which cytogenetic data were obtained, those tumors in which gross cytogenetic abnormalities were indicated also proved positive for at least one of the markers for neuronal, glial, or ependymal differentiation. Therefore, our data indicate that the presence of glial, neuronal, or ependymal differentiation appears to confer gross cytogenetic changes. A more intense histopathological, immunohistochemical, and molecular cytogenetic study beyond the scope of this report will be required to validate this observation. Nevertheless, previous studies that have attempted to correlate the presence of glial and neuronal differentiation in PNETs to outcome to date have not been found to be statistically significant. 32, 34 However, Nicholson and associates 34 did find a significant correlation between the identification of positive GFAP staining and the presence of 17p loss without 17q gain. Supporting this observation, our CGH data revealed one tumor that reacted positively for GFAP with the loss of 17p and no reciprocal gain of 17q (Case 13). Furthermore, one case (Case 14) indicated a gain of 17q without a reciprocal loss of 17p and stained negative for GFAP, also consistent with the observations of Nicholson and associates. Recent literature suggests that there are distinct cytogenetic changes between supratentorial and infratentorial PNETs, 34, 44 namely the lack of 17q gain or 17p loss associated with supratentorial PNETs. The five supratentorial PNETs in our study group showed a loss of 17p (Case 13), a gain of a full chromosome 17 (Case 18), and no apparent changes in chromosome 17 (Cases 5, 9, and 20) .
In the SKY analyses of five cases, three were based on archived fixed cytogenetic suspensions and two on fresh, short-term cultures. These samples were composed of four classic medulloblastomas and one PNET. Cytogenetic preparations (slides and fixed specimens) from the remaining cases were found to be unsuitable for SKY analysis because of poor storage or suboptimal morphological showing the classified colors. Two translocations were detected by SKY: der(3)t(3;7)(q11.1;q11.1) and der(10)t(10; 4)(q23?;q31?) in this metaphase. The G-banding analysis of this case revealed that the der(3), i(7q), der(10), and del(11)(p) were common rearrangements detected in most of the karyotypes analyzed (chromosome number range [48] [49] [50] [51] [52] [53] [54] [55] . As well as a number of normal karyotypes, some abnormal karyotypes contained markers and were determined by SKY to be material originating from chromosome 5 (data not shown). Beside the karyotype are the rearranged chromosomes (RGB display, classified metaphase, and G bands, respectively. data. In the five cases that were analyzed, two had inconclusive G-banded karyotypes due to poor metaphase morphological data. However, SKY analysis was able to derive additional information from such metaphase cells and detected a number of structural rearrangements including those found in Case 23. Double-minute chromosomes in Case 23 were identified as originating from chromosome 2. Subsequent FISH analysis using the MYCN probe confirmed that this gene was amplified. The SKY analysis of this study group revealed chromosomes 3, 7, 14, and 22 to be most commonly involved in structural or numerical rearrangements, followed by chromosomes 6 and 10. The frequency of chromosomal rearrangement detected by SKY was consistent with data generated by G-banding analysis (Fig. 1) . The ability of SKY to reveal hidden rearrangements and to identify marker chromosomes showed an increased incidence of alterations in chromosomes previously found by G-banding to be frequently altered. The difference in the detected frequency of rearrangements between G-banding and SKY analysis was likely a result of the failure to detect subtle alterations in chromosomes using conventional G-banding procedures.
The SKY analysis also revealed a higher level of tumor heterogeneity than was previously known, as indicated by the number of different stem lines containing both common and random rearrangements. Of particular interest was Case 24 in which SKY demonstrated a line containing marker chromosomes composed of chromosome 5. Subsequent CGH analysis revealed that a net gain of chromosome 5p was present in the tumor. Although detected in only one (17%) of six metaphases, the CGH result provided compelling evidence that this stem line occurs more frequently than assessed by cytogenetic analysis alone. The combination of the cytogenetic and SKY results, therefore, indicated the recurrent involvement of chromosomal abnormalities detected within the karyotype in chromosomes 7, 14, 6, 10, 3, 22, 5, 13, 17, and 18 to be approximately 10%, 9%, 8%, 8%, 8%, 8%, 7%, 7%, 7%, and 7%, respectively.
The CGH technique was applied to 10 of the 24 cases in this study. We were also able to perform all three techniques-G-banding, CGH, and SKY analysis-in three cases. Previous CGH studies 3, 34, 36, 41, 44, 48 have revealed that medulloblastomas have far more genomic imbalance than earlier classic cytogenetic studies had demonstrated. In all studies, gains of chromosomes 17q and 7 were detected in a significantly higher proportion of cases and the loss and gain of chromosomes including 3q, 5, 6, 8p, 9q, 10q, 11, 16q, and 22 have been identified. Our series of tumors also reflects similar results, showing 60% of tumors exhibit net gains of all or part of chromosomes 7 and/or 17. High-level amplification of sequences were detected in two cases and localized to 2p24 and 8q24. Both amplifications were confirmed to be amplifications of MYCN and MYCC, respectively. Another high-level gain was detected at 9p in Case 13 in which presumably the gain of 9p sequences was part of the marker chromosomes (Figs. 2  and 4) .
Of the 24 cases, six cases were confirmed to have amplified sequences of MYCN (four cases), MYCC (one case), or 9p (one case). Two other cases were found to possess double-minute chromosomes within the karyotype; however, we were unable to deduce the identity of the amplified sequences because there was insufficient tumor material for further study. Nevertheless, at least five (21%) of the 24 tumors possessed confirmed amplifications of MYCN or MYCC with an inferred total of 33% (eight of 24 cases) of our study illustrating gene amplification in the form of double-minute chromosomes. Interestingly, in most cases, MYCN was found to be amplified, rather than MYCC, which is normally associated with medulloblastoma. 12, 13 The combined results indicate that chromosomes 7 and J. Bayani, et al. spectively, of all rearrangements detected by classic cytogenetic analysis, SKY, or CGH. Chromosomes 3 (7.8%), 10 (6.7%), 14 (7%), and 22 (6.5%) were also frequently rearranged, as were chromosomes 6 (6.5%), 13 (6.2%), and 18 (6.2%). A careful search through the cytogenetic literature may reveal rearrangements involving these chromosomes. In the 1997 cytogenetic review of the literature and 120 cases published by Bhattacharjee and associates, 7 of the 21 PNETs that were karyotyped using classic cytogenetic analysis, 11 cases possessed some form of rearrangement (translocations, inversions, additions, or deletions) involving at least one of the following chromosomes: 7 (11 cases), 17 (10 cases), 13 (six cases), 3 (five cases), 10 (five cases), 18 (five cases), 22 (five cases), 6 (four cases), and 14 (four cases). In some cases, three or more chromosomes from this group were shown to have aberrations within the described karyotype.
Both restriction fragment length polymorphisms and LOH studies have detected recurrent deletion or LOH frequently involving distinct regions of chromosomes 5q, 6, 9, 10, 11, 16q, and 22. 2, 11, 14, 25, 40, 53 The results of our study indicate the increased involvement of these chromosomes in rearrangements, particularly an increase of chromosomal translocations at 5, 10q 13, and 14, often associated with near diploidy. The high percentage of rearrangements involving chromosome 10, usually through the loss of one homologue or by structural disruption at 10q, is frequently observed among glioblastomas; however, 10q LOH has been reported in medulloblastomas 25 and, in this study, we presented a case in which there was a translocation breakpoint at 10q. Present interest for positional cloning endeavors has centered on 10q23-26, where a number of candidate genes have already been identified in several solid tumors including brain tumors. 18, 31, 33 The preferential gain of 5p and its suggested pathogenic role in tumorigenesis was reported by Reardon, et al., 41 and was also found in one of our cases. The DCC gene on 18q21.1 is a candidate tumor suppressor gene that has its highest expression in the adult brain. Expression studies by Ekstrand and associates 20 determined that there was a decrease in or an absence of expression of DCC in more than 50% of the brain tumors they studied, suggesting that inactivation of this gene may be implicated in brain tumor pathogenesis.
Conclusions
The advancement of molecular cytogenetics in the past decade has allowed for an increased sensitivity in the detection of chromosomal rearrangements that may significantly alter the pattern of recurrent structural abnormalities present in medulloblastomas and PNETs. Together with histopathological and immunohistochemical findings, a correlation between pathological changes and specific chromosomal or genomic changes, as determined by the most advanced molecular cytogenetic methods, can be made, leading to better subtype diagnosis, treatment, and early detection of disease recurrence.
